These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 26068795)

  • 1. Synthesis of 8-hydroxy-2-iminochromene derivatives as selective and potent inhibitors of human carbonyl reductase 1.
    Hu D; Miyagi N; Arai Y; Oguri H; Miura T; Nishinaka T; Terada T; Gouda H; El-Kabbani O; Xia S; Toyooka N; Hara A; Matsunaga T; Ikari A; Endo S
    Org Biomol Chem; 2015 Jul; 13(27):7487-99. PubMed ID: 26068795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationship of flavonoids as potent inhibitors of carbonyl reductase 1 (CBR1).
    Arai Y; Endo S; Miyagi N; Abe N; Miura T; Nishinaka T; Terada T; Oyama M; Goda H; El-Kabbani O; Hara A; Matsunaga T; Ikari A
    Fitoterapia; 2015 Mar; 101():51-6. PubMed ID: 25549925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and structure-activity relationship of 2-phenyliminochromene derivatives as inhibitors for aldo-keto reductase (AKR) 1B10.
    Endo S; Hu D; Suyama M; Matsunaga T; Sugimoto K; Matsuya Y; El-Kabbani O; Kuwata K; Hara A; Kitade Y; Toyooka N
    Bioorg Med Chem; 2013 Nov; 21(21):6378-84. PubMed ID: 24071447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human carbonyl reductase 1 participating in intestinal first-pass drug metabolism is inhibited by fatty acids and acyl-CoAs.
    Hara A; Endo S; Matsunaga T; El-Kabbani O; Miura T; Nishinaka T; Terada T
    Biochem Pharmacol; 2017 Aug; 138():185-192. PubMed ID: 28450226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromene-3-carboxamide derivatives discovered from virtual screening as potent inhibitors of the tumour maker, AKR1B10.
    Endo S; Matsunaga T; Kuwata K; Zhao HT; El-Kabbani O; Kitade Y; Hara A
    Bioorg Med Chem; 2010 Apr; 18(7):2485-90. PubMed ID: 20304656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and evaluation of caffeic acid phenethyl ester-based inhibitors targeting a selectivity pocket in the active site of human aldo-keto reductase 1B10.
    Soda M; Hu D; Endo S; Takemura M; Li J; Wada R; Ifuku S; Zhao HT; El-Kabbani O; Ohta S; Yamamura K; Toyooka N; Hara A; Matsunaga T
    Eur J Med Chem; 2012 Feb; 48():321-9. PubMed ID: 22236472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the substrate-binding site of human carbonyl reductases CBR1 and CBR3 by site-directed mutagenesis.
    El-Hawari Y; Favia AD; Pilka ES; Kisiela M; Oppermann U; Martin HJ; Maser E
    Chem Biol Interact; 2009 Mar; 178(1-3):234-41. PubMed ID: 19061875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative Analysis of mRNA and Protein Expression Levels of Aldo-Keto Reductase and Short-Chain Dehydrogenase/Reductase Isoforms in the Human Intestine.
    Hirosawa K; Fujioka H; Morinaga G; Fukami T; Ishiguro N; Kishimoto W; Nakase H; Mizuguchi H; Nakajima M
    Drug Metab Dispos; 2023 Dec; 51(12):1569-1577. PubMed ID: 37722844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the Canine Anthracycline-Metabolizing Enzyme Carbonyl Reductase 1 (cbr1) and the Functional Isoform cbr1 V218.
    Ferguson DC; Cheng Q; Blanco JG
    Drug Metab Dispos; 2015 Jul; 43(7):922-7. PubMed ID: 25918240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. X-ray structure of the V301L aldo-keto reductase 1B10 complexed with NADP(+) and the potent aldose reductase inhibitor fidarestat: implications for inhibitor binding and selectivity.
    Ruiz FX; Cousido-Siah A; Mitschler A; Farrés J; Parés X; Podjarny A
    Chem Biol Interact; 2013 Feb; 202(1-3):178-85. PubMed ID: 23295227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flavonoids as inhibitors of human carbonyl reductase 1.
    Carlquist M; Frejd T; Gorwa-Grauslund MF
    Chem Biol Interact; 2008 Jul; 174(2):98-108. PubMed ID: 18579125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human carbonyl reducing enzymes by plant anthrone and anthraquinone derivatives.
    Westermann M; Adomako-Bonsu AG; Thiele S; Çiçek SS; Martin HJ; Maser E
    Chem Biol Interact; 2022 Feb; 354():109823. PubMed ID: 35065925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on reduction of S-nitrosoglutathione by human carbonyl reductases 1 and 3.
    Staab CA; Hartmanová T; El-Hawari Y; Ebert B; Kisiela M; Wsol V; Martin HJ; Maser E
    Chem Biol Interact; 2011 May; 191(1-3):95-103. PubMed ID: 21256830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver.
    Kassner N; Huse K; Martin HJ; Gödtel-Armbrust U; Metzger A; Meineke I; Brockmöller J; Klein K; Zanger UM; Maser E; Wojnowski L
    Drug Metab Dispos; 2008 Oct; 36(10):2113-20. PubMed ID: 18635746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of 23-hydroxybetulinic acid on doxorubicin-induced cardiotoxicity: a correlation with the inhibition of carbonyl reductase-mediated metabolism.
    Zhou F; Hao G; Zhang J; Zheng Y; Wu X; Hao K; Niu F; Luo D; Sun Y; Wu L; Ye W; Wang G
    Br J Pharmacol; 2015 Dec; 172(23):5690-703. PubMed ID: 25363561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent inhibition of human carbonyl reductase 1 (CBR1) by the prenylated chalconoid xanthohumol and its related prenylflavonoids isoxanthohumol and 8-prenylnaringenin.
    Seliger JM; Martin HJ; Maser E; Hintzpeter J
    Chem Biol Interact; 2019 May; 305():156-162. PubMed ID: 30849340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Carbonyl Reductase 1 Safely Improves the Efficacy of Doxorubicin in Breast Cancer Treatment.
    Jo A; Choi TG; Jo YH; Jyothi KR; Nguyen MN; Kim JH; Lim S; Shahid M; Akter S; Lee S; Lee KH; Kim W; Cho H; Lee J; Shokat KM; Yoon KS; Kang I; Ha J; Kim SS
    Antioxid Redox Signal; 2017 Jan; 26(2):70-83. PubMed ID: 27357096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective inhibition of the tumor marker aldo-keto reductase family member 1B10 by oleanolic acid.
    Takemura M; Endo S; Matsunaga T; Soda M; Zhao HT; El-Kabbani O; Tajima K; Iinuma M; Hara A
    J Nat Prod; 2011 May; 74(5):1201-6. PubMed ID: 21561086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin is a tight-binding inhibitor of the most efficient human daunorubicin reductase--Carbonyl reductase 1.
    Hintzpeter J; Hornung J; Ebert B; Martin HJ; Maser E
    Chem Biol Interact; 2015 Jun; 234():162-8. PubMed ID: 25541467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of Potent and Selective Inhibitors of Aldo-Keto Reductase 1B10 and Their Efficacy against Proliferation, Metastasis, and Cisplatin Resistance of Lung Cancer Cells.
    Endo S; Xia S; Suyama M; Morikawa Y; Oguri H; Hu D; Ao Y; Takahara S; Horino Y; Hayakawa Y; Watanabe Y; Gouda H; Hara A; Kuwata K; Toyooka N; Matsunaga T; Ikari A
    J Med Chem; 2017 Oct; 60(20):8441-8455. PubMed ID: 28976752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.